The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid:: A highly potent V2 agonist

被引:16
|
作者
Kowalczyk, Wioleta
Sobolewski, Dariusz
Prahl, Adam
Derdowska, Izabela
Borovickova, Lenka
Slaninova, Jirina
Lammek, Bernard
机构
[1] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland
[2] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic
关键词
D O I
10.1021/jm070174s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study we present the synthesis and some pharmacological properties of nine new analogues of arginine vasopressin modified in the N-terminal part of the molecule with 2-aminoindane-2-carboxylic acid (Aic). The peptides were tested for their in vitro uterotonic and in vivo pressor and antidiuretic activities. One of the new peptides, [Mpa(1),Aic(2),Val(4),D-Arg(8)]VP, exhibited an antidiuretic activity similar to that of [Mpa(1),D-Arg(8)]VP, thus being one of the most potent antidiuretic vasopressin analogues reported to date.
引用
收藏
页码:2926 / 2929
页数:4
相关论文
共 50 条
  • [21] VASOACTIVE EFFECTS OF ARGININE-VASOPRESSIN IN HEALTHY-SUBJECTS AND PATIENTS WITH A V2 RECEPTOR DEFECT
    VANLIEBURG, AF
    KNOERS, VVAM
    MONNENS, LAH
    THIEN, T
    SMITS, P
    KIDNEY INTERNATIONAL, 1995, 48 (04) : 1364 - 1364
  • [22] 2-amino-4-pyrrolidinothieno[2,3-d]pyrimidine-6-carboxylic acid as an N-terminal surrogate in amino acid and peptide analogues
    Bissyris, EE
    Belekos, D
    Magafa, V
    Tsoungas, PG
    Varvounis, G
    Cordopatis, P
    SYNTHESIS-STUTTGART, 2005, (18): : 3159 - 3166
  • [23] Effects of vasopressin (VP) V2 receptor agonist dDAVP in male and female spontaneously hypertensive rats (SHR)
    Ye, DL
    Uyehara, CFT
    FASEB JOURNAL, 2001, 15 (05): : A1153 - A1153
  • [24] Nonpeptide antagonists for vasopressin receptors -: Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist
    Serradeil-Le Gal, C
    VASOPRESSIN AND OXYTOCIN: MOLECULAR, CELLULAR, AND CLINICAL ADVANCES, 1998, 449 : 427 - 438
  • [25] EFFECTS OF ARGININE-VASOPRESSIN AND 1-DESAMINO-8-D-ARGININE VASOPRESSIN ON FOREARM VASCULATURE OF HEALTHY-SUBJECTS AND PATIENTS WITH A V2 RECEPTOR DEFECT
    VANLIEBURG, AF
    KNOERS, VVAM
    MONNENS, LAH
    SMITS, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 672 - 672
  • [26] Differential Responses of the GLP-1 and GLP-2 Receptors to N-Terminal Modification of a Dual Agonist
    Gibadullin, Ruslan
    Cary, Brian P.
    Gellman, Samuel H.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2023, 145 (22) : 12105 - 12114
  • [27] 2,5-disubstituted 3,4-dihydro-2H-benzo[b][1,4]thiazepines as potent and selective V2 arginine vasopressin receptor antagonists
    Urbanski, MJ
    Chen, RH
    Demarest, KT
    Gunnet, J
    Look, R
    Ericson, E
    Murray, WV
    Rybczynski, PJ
    Zhang, XY
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) : 4031 - 4034
  • [28] Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia
    Miyazaki, T
    Yamamura, Y
    Onogawa, T
    Nakamura, S
    Kinoshita, S
    Nakayama, S
    Fujiki, H
    Mori, T
    ENDOCRINOLOGY, 2005, 146 (07) : 3037 - 3043
  • [29] [2′,6′-dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group:: Potent and selective κ opioid antagonists
    Lu, YX
    Nguyen, TMD
    Weltrowska, G
    Berezowska, I
    Lemieux, C
    Chung, NN
    Schiller, PW
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (19) : 3048 - 3053